Dr. Mohamed Maait, Minister of Finance, announced the approval of 2 billion pounds to provide vaccinations for the Corona virus and to face the repercussions of the third wave of the virus, pointing out that 13.2 billion additional funds have been made available to the health sector in its various institutions, since the beginning of the current fiscal year until now, of which 1.3 billion have been provided to university hospitals. .
In addition, the head of the Russian “Gamalia” Center for Microbiology, Alexander Ginsburg, said that the clinical test for the first “nasal” vaccine against the virus will begin at the end of 2021 or early 2022, and it will be registered in 2022.
He explained that the center is constantly working on developing new vaccines and updating existing vaccines, and among the new vaccines is a vaccine that is injected through the nose, and its preclinical tests are now being conducted, and its clinical tests are scheduled to start at the end of this year or early next year, and the Russian official indicated that it is assumed that The vaccine is injected first with two doses, but it is not unlikely that only one dose will be used in the future.
In a related context, the German researcher, Dr. Andreas Greenscher, discovered that the chemical in the “AstraZeneca” vaccine leads to an immune reaction that produces those rare side effects that were recorded in a few people who received the vaccine, including blood clots, and explained that the inflammation caused by Vaccines trick the immune system into believing that the body has been infected with the bacteria, which leads to an old defense mechanism that gets out of control, causing clotting and bleeding.